NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 87 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $252,000 | -59.0% | 130,654 | +1.1% | 0.00% | – |
| Q4 2021 | $614,000 | -46.8% | 129,175 | -7.8% | 0.00% | – |
| Q3 2021 | $1,155,000 | -11.1% | 140,110 | -0.5% | 0.00% | – |
| Q2 2021 | $1,299,000 | -25.6% | 140,760 | -0.8% | 0.00% | -100.0% |
| Q1 2021 | $1,747,000 | -58.8% | 141,881 | -52.8% | 0.00% | 0.0% |
| Q4 2020 | $4,242,000 | +15.4% | 300,846 | -1.8% | 0.00% | 0.0% |
| Q3 2020 | $3,675,000 | +6.3% | 306,212 | +47.0% | 0.00% | 0.0% |
| Q2 2020 | $3,458,000 | – | 208,295 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 199,000 | $205,000 | 0.29% |
| Opaleye Management Inc. | 610,000 | $628,000 | 0.28% |
| Redmile Group, LLC | 3,436,935 | $3,540,000 | 0.14% |
| Kynam Capital Management, LP | 124,701 | $128,000 | 0.03% |
| Baker Brothers Advisors | 3,821,740 | $3,936,000 | 0.02% |
| Sio Capital Management, LLC | 38,312 | $39,000 | 0.02% |
| Candriam S.C.A. | 781,577 | $805,000 | 0.01% |
| Highland Private Wealth Management | 46,999 | $48,000 | 0.01% |
| SIMON QUICK ADVISORS, LLC | 46,856 | $49,000 | 0.01% |
| Point72 Asset Management, L.P. | 1,437,417 | $1,481,000 | 0.01% |